Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus Infections
流感病毒感染期间先天免疫系统的心脏保护机制
基本信息
- 批准号:9809007
- 负责人:
- 金额:$ 22.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral AgentsApoptosisAutopsyCardiacCardiac MyocytesCardiovascular DiseasesCellsDefectDevelopmentFeedbackFibroblastsFibrosisFlow CytometryFunctional disorderGene ExpressionGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseHeartHumanImmuneImmunologistIn VitroIndividualInduction of ApoptosisInfectionInflammationInflammatoryInfluenzaInnate Immune SystemIntegral Membrane ProteinInterferonsKnockout MiceKnowledgeLightLinkMeasuresMyocardial InfarctionMyocardial dysfunctionMyocarditisOutcomePathogenesisPathologyPathway interactionsPatientsPredispositionPrevention strategyProteinsReportingResearchRoleSeasonsSepsisStainsTestingTissuesVaccinationViral AntigensVirusVirus DiseasesVirus ReplicationWestern BlottingWorkcardioprotectioncombatcoronary fibrosisexperimental studyfluheart damageheart functionin vivoinfluenzavirusinsightmouse modelnew therapeutic targetpandemic influenzapreservationpreventrecruitresponseseasonal influenzaspreading factortargeted treatmenttrafficking
项目摘要
SUMMARY
Although influenza virus has been known for more than a century to be a cause of infectious myocarditis, the
underlying mechanisms and susceptibility factors for these cardiac complications are not well understood.
Cardiac dysfunction is primarily seen in severe infections, and severe influenza in humans has been
reproducibly linked to deleterious polymorphisms in the Interferon-Induced Transmembrane Protein 3 (IFITM3)
gene. IFITM3 is an innate immune protein that blocks virus entry into cells and regulates inflammatory immune
pathways. Despite the knowledge that IFITM3 influences the outcome of human infections, its role in cardiac
complications of influenza has not been previously investigated. Our experiments using a newly developed
IFITM3 knockout mouse model indicate that IFITM3 is essential for limiting influenza virus spread to the heart
and for preventing cardiac fibrosis and electrical dysfunction caused by the virus. We have also observed that
immune cells are depleted from hearts of IFITM3 knockout mice during infection, thus preventing cardiac
clearance of virus. In Aim 1, we will investigate the cause of this immune cell depletion by testing the
hypothesis that IFITM3-deficient immune cells residing in, or recruited to, the heart are directly infected by virus
and undergo apoptosis. In Aim 2, we will identify the mechanism by which fibrosis and cardiac dysfunction
occur during infection by testing the hypothesis that virus infection activates specific inflammatory and fibrotic
gene profiles in cardiomyocytes and cardiac fibroblasts in the absence of IFITM3. Overall, our research will
reveal mechanisms underlying cardiac fibrosis and dysfunction in severe influenza virus infections and will thus
identify new strategies for combatting this infection-induced pathology.
摘要
尽管流感病毒被认为是感染性心肌炎的原因已有一个多世纪的历史,但
这些心脏并发症的潜在机制和易感因素尚不清楚。
心脏功能不全主要见于严重感染,人类严重流感
重复性与干扰素诱导的跨膜蛋白3(IFITM3)的有害多态相关
吉恩。IFITM3是一种天然免疫蛋白,可阻止病毒进入细胞并调节炎症免疫
小路。尽管知道IFITM3影响人类感染的结局,但它在心脏疾病中的作用
流感的并发症以前没有被调查过。我们的实验使用了一种新开发的
IFITM3基因敲除小鼠模型表明IFITM3对于限制流感病毒传播到心脏是必不可少的
并用于预防病毒引起的心脏纤维化和电功能障碍。我们还观察到,
在感染期间,IFITM3基因敲除小鼠心脏中的免疫细胞被耗尽,从而防止心脏
清除病毒。在目标1中,我们将通过测试
假设驻留在心脏或招募到心脏的IFITM3缺陷免疫细胞直接受到病毒感染
并经历细胞凋亡。在目标2中,我们将确定纤维化和心功能不全的机制。
通过检验病毒感染激活特定炎症和纤维化的假设,在感染期间发生
在缺乏IFITM3的情况下心肌细胞和心脏成纤维细胞的基因图谱。总体而言,我们的研究将
揭示严重流感病毒感染的心脏纤维化和功能障碍的机制,因此
确定抗击这种由感染引起的病理的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Murugesan Rajaram其他文献
Murugesan Rajaram的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Murugesan Rajaram', 18)}}的其他基金
Role of Aging on cardiac macrophage dysfunction and heart failure during infection
衰老对感染期间心脏巨噬细胞功能障碍和心力衰竭的作用
- 批准号:
10620781 - 财政年份:2022
- 资助金额:
$ 22.72万 - 项目类别:
Role of Aging on cardiac macrophage dysfunction and heart failure during infection
衰老对感染期间心脏巨噬细胞功能障碍和心力衰竭的作用
- 批准号:
10447405 - 财政年份:2022
- 资助金额:
$ 22.72万 - 项目类别:
Molecular mechanism of cardiac inflammation and dysfunction in Pseudomonas aeruginosa infection
铜绿假单胞菌感染心脏炎症和功能障碍的分子机制
- 批准号:
10436279 - 财政年份:2019
- 资助金额:
$ 22.72万 - 项目类别:
Molecular mechanism of cardiac inflammation and dysfunction in Pseudomonas aeruginosa infection
铜绿假单胞菌感染心脏炎症和功能障碍的分子机制
- 批准号:
10654794 - 财政年份:2019
- 资助金额:
$ 22.72万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 22.72万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 22.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 22.72万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 22.72万 - 项目类别:
Discovery Grants Program - Individual